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INTRODUCTION
In clinical settings, co-morbid substance 
abuse disorders are common among people 
receiving in-patient psychiatric treatment 
(Eisen, Youngman, Grob, & Dill, 1992; Greene, 
Ennett, & Ringwalt, 1997) and conversely, 
psychiatric co-morbidity is common in those 
in treatment programs for addiction (Bukstein 
& Kaminer, 1994; Kaminer, Bukstein, & 
Tarter, 1991; Stowell & Estroff, 1992).  Most 
studies have generally found that onset of 
psychiatric disorder precedes substance abuse 
disorder (Angold, Costello, & Erkanli, 1999; 
Brook, Whiteman, Gordon, & Cohen, 1986; 
Brook, Whiteman, Finch, & Cohen, 1996; 
Elliot, Huizinga, & Menard, 1988; Rohde, 
Lewinsohn, & Seeley, 1996; van Kammen 
& Loeber, 1994).  This may be related to a 
Diagnostic and Statistical Manual of Mental 
Disorders –  Version IV (DSM – IV) (American 
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Psychiatric Association [APA], 1994) criteria 
for substance abuse and dependence than for 
other disorders.  Thus the likelihood that an 
individual will seek treatment for a particular 
disorder increases the presence of a second 
co-existing disorder (Boyle & Offord, 1991; 
Brook, Cohen, & Brook, 1998).
abuse and alcoholism in the United States of 
America (USA) and Canada (World Health 
Organisation, 2004; Rehm, Baliunas, Brochu, 
Fischer, Gnam, Patra, Popova, Samocinska-
Hart, & Taylor, 2006) showed that there were 
both direct and indirect costs.  The magnitude of 
showed for example, the overall economic 
cost of drug abuse in the United States rising 
at the rate of 5.3 percent annually from $107.5 
billion in 1992 to an estimated $180.9 billion 
in 2002.  Direct costs included those arising 
from medical expenditures to treat the medical 
and law enforcement efforts to curb crime 
attributable to drug use. Other direct costs 
were vehicle collision damage as a result of 
motor accidents caused by drunken driving, 
of sensory judgement or physical function 
by alcohol consumption and a range of costs 
associated with providing employee support at 
in the workplace or at home, premature death, 
illness and injury as a result of alcohol use 
were all considered under indirect costs. In 
South Africa, the health, social and economic 
alcohol use have been documented as the 
burden of harm under the same dimensions 
as those presented earlier (Parry, 2000).  In 
a survey by Whyte (1991) carried out in 
was mentioned 45 times in a sample of 170 
subjects.  Families spent large sums of money 
in payment to traditional healers.
There is no documented study in Kenya that 
focuses on the co-morbidity of substance abuse 
and psychiatric disorders in patients.  The aim 
or not there is a co-morbidity of substance abuse 
disorder with psychiatric disorders among in-
patients admitted at Mathari hospital. 
METHOD
In an attempt to improve comprehensive 
history-taking in line with DSM-IV-TR (Text 
Revision) criteria (American Psychiatric 
Association [APA], 1994), the Structured
Clinical Interview for DSM-III-R Diagnoses
(SCID) (Spitzer, Williams, & Gibbon, & First, 
1990) format was used on all patients admitted 
at the Mathari Hospital over a period of one 
month in June 2004.  The SCID provides 
diagnosis.  Experienced psychiatric nurses 
were trained for this exercise in an attempt to 
test the feasibility of adopting this procedure. 
This was done in order to improve and 
control exercise in the routine care of patients. 
Informed consent was obtained only from 
those who were not too sick or too disturbed 
to participate in the study.  Those who were 
very sick were recruited into the study through 
assent and consent for their participation was 
obtained from their caregivers.  A total of 
691 patients were recruited.  Those who met 
the SCID criteria of substance abuse were 
further interviewed using a semi-structured 
socio-economic characteristics.
For each patient, the hospital diagnosis 
and clinical management data were extracted 
from their notes. The data were analysed using 
SPSS version 11.0. The DSM-IV diagnoses 
of alcohol, substance abuse and psychiatric 
disorders were correlated with clinical 
diagnoses in the same patients. 
RESULTS
The data collected showed that this was a 
relatively young population (age range: 17 – 
64 years; mean age: 31.97 years) as 82.1% 
were aged 40 years and below.  More than 
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half (58.4%; n = 139) of the patients were 
single, 26.1% (n = 62) were married while 
12.6% (n = 30) were widowed, divorced or 
separated. More than one third (34.4%; n = 
238) of the patients met the DSM-IV criteria 
for a substance abuse disorder and all of them 
had a diagnosis of alcohol dependence.  The 
proportion of male patients in this group was 
82.4% while that of females was 17.6%.  Of 
those with a substance abuse disorder (n = 
238), 55.9% (n = 133) or 19.2% of the total 
sample (N = 691) were dependent on opiates. 
total sample, were dependent on sedatives, 
while 140 (58.8% of the substance abusers or 
20.3% of the total sample) recorded stimulant 
dependence.
The hospital and differential diagnoses of 
the 238 patients are summarised in Table 1. 
Schizophrenia accounted for 34% (n = 81) of 
common diagnosis.  It was followed in order 
by other psychotic disorders (29%), mood 
disorder (20.2%) and substance abuse disorder 
(13.0%).  It is noteworthy that although 
alcohol dependence was the most common 
SCID substance abuse disorder, it was hardly 
recorded as a hospital diagnosis.
Table 2 summarises the correlations 
substance abuse disorders, and between 
alcohol and other drugs.  The results suggest 
high co-morbidity of SCID core symptoms 
with alcohol and other drugs and also, co-
morbidity between alcohol and other drugs. 
When the DSM-IV diagnoses of alcohol, 
substance abuse and psychiatric disorders 
were correlated with clinical diagnoses in 
the same patients, the highest number of 
psychiatric disorders and alcohol abuse. The 
correlations of minor depressive and recurrent 
grief disorders with alcohol abuse were very 
there was co-morbidity of all substance abuse 
with depressive episodes, dysthmia and minor 
depressive episode. The other correlations 
DISCUSSION
The results showed that a majority of the 
patients with DSM-IV-TR substance abuse 
diagnoses.  Schizophrenia was diagnosed 
disorders, mood disorders and substance abuse 
disorder.  There was likelihood that people in 
the community with substance abuse disorder 
only seek treatment if a co-existing psychiatric 
disorder starts to manifest itself.  The co-
existing disorder makes patients unable to 





D1 D2 D3 D4
Adjustment disorder 0 3 1 0
Mood disorder 48 3 2 0
Delusional disorder 1 1 0 0
Psychotic disorders 69 10 1 0
PTSD 1 0 0 0
Schizo-affective disorder 6 3 0 0
Schizophrenia 81 12 4 1
Substance use disorder 31 15 3 0
N 238 44 11 1
*D1 – Working diagnosis
D2 – 2nd working diagnosis
D3 – 3rd working diagnosis
D4 – 4th working diagnosis
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function or adjust effectively in the society. 
from the US (Brook et al., 1998; Bailey, 1992). 
The patients may have started using substances 
psychological risks such as other psychiatric 
disorders provided a basis for picking the 
habit.  This was demonstrated by the strong 
abuse and certain psychiatric conditions. 
However, the relationship between substance 
abuse and co-morbid psychiatric disorders 
scope of this study to determine whether or not 
psychiatric symptoms or disorders developed 
vice versa. 
The fact that a substance abuse disorder 
did not lead to help-seeking behaviour by 
that less than 5% had taken the initiative to 
look for help for a drug use problem.  Alcohol 
substance abuse disorder (see Table 2).  Once 
an individual started using one substance of 
dependence, the risk of using other substances 
seemed to increase (Bailey, 1992).  The 
mental and substance abuse disorders is a 
Kaminer, 1994; Eisen et al., 1992; Elliot et al., 
1988; Greene et al., 1997; Kaminer et al., 1991; 
Rohde et al., 1996; Stowell & Estroff, 1992). 
Therefore, by the time the patients sought 
psychiatric treatment, they were presenting 
with more than one substance abuse disorder, 
in the US and Canada (Bailey, 1992; Brook et 
al., 1998; Boyle & Offord, 1991).
minor depressive illness and alcohol (p<0.01) 
and stimulant use (p<0.01) is not surprising 
Table 2. (Pearson
correlations)
Disorders Alcohol Opioids Sedatives Stimulants
Depressive episode .000 (a) .239 .060
Dysthmia .532 (a) .048 .000
Minor depressive disorder .745 (**) (a) .118 .856 (**)
Recent major depressive episode -1.000 (**) (a) (a) (a)
Past major depressive episode -1.000 (**) (a) (a) (a)
Current manic episode -1.000 (**) (a) (a) (a)
Autonomic symptoms .141 .089 -.145 -1.000 (**)
Panic disorder .542 -1.000 (**) .816 (a)
Delusions -.575 -.873 .341 (a)
PTSD1 (past) (a) .316 -.404 -.667
PTSD3 (current)                                                  .010 .001 .001 .001
Generalized anxiety disorder -.417 -.816 -.937 (*) (a)
Acute stress disorder -.172 .971 .971 (a)
Sedatives -.525 (*) .970 (**) .662
Stimulants  ( ) -.875 (a) .662
Opioids -.408 .970 (**) (a)
Hallucinations .060 (a) .271 (a)
Negative symptoms -.200 -.577 .372 (a)
Schizophrenia (a) (a) .353 (a)
Alcohol -.408 -.525 (*) -.875
Recurrent grief disorder .806 (**) (a) -.394 .000
Somatisation disorder -.577 (a) -.342 (a)
Current acute stress disorder .198 -.577 -.189 (a)
a Cannot be computed because at least one of the variables is constant.
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given that these drugs could have been used 
to give the depressed patient a sense of well-
being. This could also be inferred from the 
alcohol use and recent or past depressive 
illness – that is, the patients did not use alcohol 
when they were not currently depressed.  The 
same explanation is likely for the correlation 
between recurrent grief disorder and alcohol 
use (p<0.01).  The concurrent use of opioids 
and sedatives (p<0.010 can be explained by the 
fact that sedatives may have been used to deal 
with the anxiety and restlessness associated 
with the withdrawal effects of opioids.
The co-morbidity of autonomic symptoms 
with alcohol and opioid use was most likely 
associated with the use of these drugs, 
whereas the co-morbidity of panic disorder 
of the use of these substances to control panic 
attacks.  The co-morbidity of both delusions 
and hallucinations with sedatives illustrates 
that the sedatives were being used to treat 
the psychotic symptoms and conditions. 
Concurrent abuse of sedatives and opioids 
may have been because of the reasons already 
discussed, while simultaneous stimulant and 
sedative use (a common practice) may have 
been because sedatives are normally used to 
control the effects of stimulants. Noteworthy 
is that there was no co-morbidity of use 
of alcohol with other drugs. The negative 
correlation between current manic episodes 
and alcohol use was contrally to expectation 
as uninhibited patients as happens in mania are 
likely to indulge in alcohol. In summary, the 
study showed that substance abuse disorders 
remain undiagnosed and are therefore not 
managed.  There was high co-morbidity of 
DSM-IV diagnoses of alcohol dependence 
with other substance abuse disorders as well as 
with psychiatric conditions.  Several DSM-IV-
correlations with DSM-IV diagnoses of 
substance abuse disorder.  These results 
have profound clinical and practice policy 
and dual management is critical as they call 
for compressive history taking, regardless 
of the presenting condition.  This practice 
rehabilitation units as well as in community 
and home-based (out-patient) management. 
Failure to recognise dual diagnosis in a 
substance abuse disorder will mean that only 
partial treatment and management is provided 
to the patient.  Collateral information will 
assist in the authentication of whether or not a 
substance abuse disorder exists.
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